THE CBD INITIATIVE
As a leader in nutraceutical development, Inergetics is launching the CBD Initiative focused on exploring the growth, extraction and development of cannabinoid based nutritional products. While THC (tetrahydrocanabinol) found in medical marijuana was the focus of attention in the past, evolving research on other non-psychoactive cannabinoids such as CBD (cannabidiol) addressing a variety of clinical conditions including pain, nausea, seizures, eye and brain health are on the forefront of evidenced based medicine and nutritional science. Acknowledging the wealth of published data unraveling the medical benefits of cannabinoids, Inergetics plans to be a leader in providing various marketplaces with pharmaceutical grade nutritional products.
Helping us to better understand cannabinoids and the advances that are taking place in the laboratory and physician’s office, Inergetics has assembled a collective of accomplished physicians and PhD’s to man its Medical/Scientific Advisory Board. With much of the new literature aimed at advances in laboratory techniques for isolation, detection and extraction of cannabinoids; awareness of the various cannabinoids expressing therapeutic effects; and clinical application, we look forward to our Board to provide their experience and insights to help guide us in our product development.
Inergetics is proud to work with its strategic partner Terra Tech (TRTC) to embark on the CBD Initiative to provide patients and consumers the first comprehensive line of CBD-based nutraceuticals.
News 
Market Data 
Discover 
AI
